Press Releases

May 8, 2024
SAN JOSE, Calif. --(BUSINESS WIRE)--May 8, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March
May 6, 2024
SAN JOSE, Calif. --(BUSINESS WIRE)--May 6, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k)
May 1, 2024
SAN JOSE, Calif. --(BUSINESS WIRE)--May 1, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that members of management will participate at the BofA Securities
February 26, 2024
SAN JOSE, Calif. --(BUSINESS WIRE)--Feb. 26, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,   today announced that members of management will present at the 44 th annual TD
February 21, 2024
SAN JOSE, Calif. --(BUSINESS WIRE)--Feb. 21, 2024-- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full